Thomas Kurt Eigentler

28PUBLICATIONS
70CO-AUTHORS
Predictive and prognostic markersCancer diagnosisTumour immunologyCardiovascular medicine and haematology not elsewhere classifiedCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (28)

|Jul 02, 2026
Years of life lost in patients with a false-negative diagnosis of primary melanoma. A prospective study of the German Central Malignant Melanoma Registry involving 9063 patients over 28 years.

|May 25, 2026
Years of life lost in cutaneous squamous cell carcinoma: analysis of a prospective cohort of 1400 patients.

|Mar 26, 2026
European Standard Clinical Practice Recommendations for Cutaneous Melanoma in Children and Adolescents.

Luca Bergamaschi, Alice Indini, Ines B Brecht

|Jan 20, 2026
Vδ1 T-cell subset appears to be responsive to PD-1 blockade therapy and is associated with survival in melanoma.

Nicola Herold, Jonas Bochem, Johanna Leyens

|Dec 11, 2025
Correction: Hassel et al. Medical Needs and Therapeutic Options for Melanoma Patients Resistant to Anti-PD-1-Directed Immune Checkpoint Inhibition. Cancers 2023, 15, 3448.

Jessica C Hassel, Lisa Zimmer, Thomas Sickmann

|Feb 04, 2025
Phase I study of intratumoral administration of CV8102 in patients with advanced melanoma, squamous cell carcinoma of the skin, squamous cell carcinoma of the head and neck, or adenoid cystic carcinoma.

Thomas Eigentler, Ioannis Thomas, Igor Samoylenko

Pageof 5

Frequent Collaborators

4 joint publications

Friedegund Meier

4 joint publications

Andrea Forschner

4 joint publications

Teresa Amaral

4 joint publications

Claus Garbe